These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7529277)

  • 21. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
    Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE
    Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble adhesion molecules in juvenile rheumatoid arthritis.
    Bloom BJ; Miller LC; Tucker LB; Schaller JG; Blier PR
    J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble adhesion molecules and endothelial cell damage in HIV infected patients.
    Seigneur M; Constans J; Blann A; Renard M; Pellegrin JL; Amiral J; Boisseau M; Conri C
    Thromb Haemost; 1997 Apr; 77(4):646-9. PubMed ID: 9134636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
    Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
    J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.
    Blann AD; Davis A; Miller JP; McCollum CN
    Am J Hematol; 1997 May; 55(1):15-23. PubMed ID: 9136912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
    Chong AY; Lip GY; Freestone B; Blann AD
    Eur J Heart Fail; 2006 Mar; 8(2):167-72. PubMed ID: 16185922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
    Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy].
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Aschermann M; Horký K
    Vnitr Lek; 2002 Aug; 48(8):718-23. PubMed ID: 12425201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.
    Blann A; Kumar P; Krupinski J; McCollum C; Beevers DG; Lip GY
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):277-84. PubMed ID: 10456619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.
    Preston RA; Ledford M; Materson BJ; Baltodano NM; Memon A; Alonso A
    J Hypertens; 2002 May; 20(5):871-7. PubMed ID: 12011647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor.
    Blann AD; Goode GK; Miller JP; McCollum CN
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):200-4. PubMed ID: 9167022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
    Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
    Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia.
    Blann AD; Miller JP; McCollum CN
    Atherosclerosis; 1997 Jul; 132(2):151-6. PubMed ID: 9242960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: An observational, controlled pilot study in Taiwanese adults.
    Hwang YS; Tsai WC; Lu YH; Lin CC; Tsai KY
    Curr Ther Res Clin Exp; 2005 May; 66(3):181-94. PubMed ID: 24672122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype.
    Kozuka K; Kohriyama T; Nomura E; Ikeda J; Kajikawa H; Nakamura S
    Atherosclerosis; 2002 Mar; 161(1):161-8. PubMed ID: 11882328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin.
    Blann AD; de Romeuf C; Mazurier C; McCollum CN
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):261-6. PubMed ID: 9663709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of the TGF-beta receptor are increased in atherosclerosis.
    Blann AD; Wang JM; Wilson PB; Kumar S
    Atherosclerosis; 1996 Feb; 120(1-2):221-6. PubMed ID: 8645363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.